Acurion is a precision oncology technology company that develops the OncoGaze™ platform for AI-driven cancer biomarker detection.
The company focuses on applying advanced computational methods to analyze biomedical data and support clinical decision-making and diagnostic workflows in oncology.
Leadership & Board
Current Number of Employees16
Current LinkedIn Followers788
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$4M
Total Amount Raised$4M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$4M
Latest Funding Amount$4M
Latest Funding RoundSeed Round
Latest Funding RoundSeed Round
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Acurion had 16 employees as of September 28, 2026. The number of employees increased by 0 (0.00%) week-over-week.
16Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Acurion had 788 followers as of September 28, 2026. The number of followers increased by 4 (0.51%) week-over-week.
788Latest Followers Count
4(0.51%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.